burk
cunha
md
macp
b
histori
ribbert
note
larg
cell
kidney
cell
stillborn
later
describ
protozoanlik
larg
cell
eccentr
nuclei
surround
clear
halo
ribbert
appreci
signific
find
read
report
gesionek
kiolemenogl
publish
year
describ
similar
structur
lung
liver
kidney
fetu
ribbert
laboratori
lowenstein
found
protozoanlik
larg
cell
parotid
gland
infant
lowenstein
first
appreci
larg
inclus
nucleu
pettavel
describ
similar
inclus
thyroid
gland
prematur
infant
later
good
pasteur
talbot
report
case
infant
intranuclear
eosinophil
inclus
similar
previous
describ
first
use
term
cytomegalia
believ
larg
inclus
bodi
nucleu
repres
protozoa
von
glahn
pappenheim
describ
first
adult
case
cytomegaloviru
cmv
infect
male
ameb
liver
abscess
inclus
bodi
found
lung
intestin
conclud
inclus
case
similar
seen
herp
viru
infect
chaudri
first
definit
link
intracellular
inclus
bodi
specif
viral
infect
wyatt
colleagu
report
inclus
cmv
alway
present
renal
tubul
reason
inclus
might
present
urin
specimen
also
coin
term
gener
cytomegal
inclus
diseas
first
describ
wolbach
wyatt
first
diagnos
cytomegal
inclus
diseas
cid
antemortem
infant
earli
mercer
margileth
also
show
cid
could
diagnos
demonstr
inclus
cell
void
urin
electron
microscopi
first
use
minder
visual
intracellular
inclus
cmv
pancrea
histori
cmv
repres
period
cytopatholog
later
follow
virolog
period
ender
abl
cultur
human
cell
isol
human
cmv
possibl
human
cmv
cultur
nonhuman
cell
line
late
ender
colleagu
develop
tissu
cultur
techniqu
isol
polioviru
smith
isol
mous
cmv
cell
cultur
human
cmv
cultur
human
cell
line
boston
bethesda
clemola
kariainen
first
describ
cmv
heterophileneg
infecti
mononucleosi
adult
isol
identif
cmv
led
way
sophist
diagnost
method
widespread
organ
transplant
increas
interest
cmv
import
pathogen
isol
immunosuppress
patient
case
human
immunodefici
viru
hiv
infect
retin
acalcul
cholecyst
esophag
coliti
enceph
cmv
import
infect
commonli
present
prolong
febril
respons
hallmark
cmv
infect
unexpectedli
cmv
report
caus
fever
unknown
origin
children
adult
cmv
continu
import
infect
immunocompet
host
exampl
cmv
infecti
mononucleosi
postperfus
syndrom
compromis
host
eg
patient
system
lupu
erythematosu
sle
immunosuppress
drug
eg
patient
crohn
diseas
cmv
uncommonli
present
cmv
infecti
mononucleosi
fever
unknown
origin
fuo
sever
communityacquir
pneumonia
cap
carlstrom
colleagu
first
report
case
cmv
capin
seri
cmv
infect
immunocompet
host
one
patient
woman
develop
cmv
cap
sterner
colleagu
report
case
woman
cmv
postperfus
syndrom
later
develop
cmv
cap
klemola
colleagu
report
case
cmv
cap
immunocompet
adult
klemola
report
first
describ
detail
featur
cmv
cap
immunocompet
adult
report
prolong
fever
predomin
present
sign
cmv
cap
patient
cmv
cap
woman
woman
cough
respiratori
symptom
prolong
fever
bilater
basilar
patchyinterstiti
infiltr
chest
radiograph
cxr
cmv
infiltr
resolv
slowli
week
note
diagnost
clue
cmv
cap
rel
lymphopenia
atyp
lymphocyt
mildli
elev
serum
transaminas
typic
initi
cmv
igm
titer
neg
patient
later
develop
elev
cmv
igmigg
titer
cmv
viruria
present
case
cmv
dna
virus
murin
human
varieti
cmv
dna
virus
icosahedr
capsid
capsom
viral
particl
diamet
nm
capsid
surround
phospholipidrich
envelop
cmv
member
herpesvirida
famili
consist
human
herp
virus
hhv
famili
herpesvirida
includ
herp
simplex
viru
type
type
varicellazost
viru
epsteinbarr
viru
ebv
cmv
formerli
known
also
human
herp
virus
famili
herpesvirida
divid
subfamili
repres
hsv
alphaherpesvirina
cmv
betaherpesvirina
lymphocryptovirus
gammaherpesvirina
human
cmv
one
betaherpesvirina
cmv
distinct
characterist
dna
molecular
weight
grow
human
cell
narrow
host
rang
human
grow
best
human
fibroblast
rel
slow
reproduct
cycl
hour
distinct
inclus
bodi
contain
nuclei
cytoplasm
infect
host
cell
enlarg
cytomegalia
nuclear
cytoplasm
inclus
cmv
predilect
salivari
gland
present
parotid
submandibular
gland
sublingu
gland
kidney
lung
common
site
infect
acquiredcmv
infect
morpholog
cmv
resembl
herp
virus
particularli
hsv
import
cytopath
differ
although
cellular
penetr
hsv
cmv
take
place
rapidli
intracellular
replic
cmv
much
slower
approxim
day
compar
hsv
approxim
hour
reason
slow
intracellular
replic
cmv
well
understood
although
hsv
cmv
produc
intranuclear
inclus
cmv
produc
cytoplasm
inclus
dens
bodi
cmv
produc
perinuclear
cytoplasm
inclus
cytopatholog
diagnosi
possibl
cytopatholog
chang
host
tissu
indic
activ
infect
inact
latent
infect
epidemiolog
typic
bacteri
caus
cap
may
differenti
atyp
cap
presenc
absenc
extrapulmonari
find
patient
present
cap
without
extrapulmonari
find
infect
caus
typic
bacteri
cap
pathogen
ie
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
patient
present
cap
extrapulmonari
find
atyp
cap
may
caus
zoonot
nonzoonot
atyp
pathogen
common
caus
nonzoonot
atyp
cap
legionnair
diseas
mycoplasma
pneumonia
chlamydophila
chlamydia
pneumonia
asid
usual
zoonot
nonzoonot
atyp
pathogen
caus
cap
viral
pathogen
infrequ
present
atyp
cap
cmv
adenoviru
influenza
human
avian
swine
pneumocysti
carinii
jiroveci
pcp
pcp
cmv
recogn
pathogen
compromis
host
exampl
undergo
transplant
immunosuppress
drug
steroid
howev
cmv
influenza
human
avian
swine
adenoviru
common
caus
sever
viral
cap
immunocompet
adult
immunocompromis
host
immunosuppress
drug
clinic
present
cmv
cap
well
describ
cmv
present
lung
approxim
patient
hiv
pcp
presenc
cmv
lung
biopsi
specimen
hivinfect
patient
pcp
indic
causal
role
patient
clinic
present
sever
cap
patient
pcp
treat
cap
resolv
without
specif
anticmv
therapi
cmv
cap
immunocompet
host
uncommon
recogn
frequent
particularli
present
sever
viral
cap
cap
pathogen
sever
present
cmv
cap
normal
host
vari
certainli
mani
mild
moder
sever
case
cmv
cap
go
undetect
easili
miss
mild
flu
ascrib
respiratori
viru
cmv
normal
host
like
recogn
present
sever
viral
cap
sever
cap
impli
patient
suffici
ill
cap
requir
hospit
often
ventilatori
support
patient
present
sever
cap
may
approach
clinic
degre
hypoxemia
appear
distribut
infiltr
cxr
sever
cap
may
also
mimick
noninfecti
disord
present
sever
hypoxemia
hypotens
infiltr
cxr
common
noninfecti
disord
mimick
sever
cap
pulmonari
embolu
congest
heart
failur
pulmonari
drug
reaction
pulmonari
hemorrhag
collagen
vascular
diseas
eg
sle
pneumon
sarcoidosi
clinic
decompens
patient
preexist
sever
interstiti
lung
diseas
mimic
sever
cap
usual
elimin
clinic
consider
basi
histori
physic
examin
routin
nonspecif
laboratori
featur
point
diagnosi
noninfecti
mimic
sever
cap
elimin
clinician
consid
patient
focalsegment
pulmonari
infiltr
ie
bacteri
cap
versu
patient
either
minimalno
infiltr
bilater
symmetr
interstiti
infiltr
ie
pcpviral
cap
common
bacteri
pathogen
caus
sever
cap
pneumonia
legionella
legionnair
diseas
present
focal
segment
lobar
infiltr
cxr
differenti
diagnosi
patient
present
without
focallobar
infiltr
cxr
hypoxemia
either
minim
infiltr
bilater
symmetr
interstiti
infiltr
cxr
includ
hivinfect
patient
pcp
immunosuppress
patient
patient
viral
pneumonia
influenza
human
avian
swine
sever
acut
respiratori
syndrom
sar
hantaviru
pulmonari
syndrom
hp
cmv
viral
cap
present
sever
cmv
infect
initi
present
minim
pulmonari
infiltr
cxr
accompani
variou
degre
hypoxemia
degre
hypoxemia
relat
degre
oxygen
diffus
defect
caus
interstiti
pathogen
sever
viral
cap
normal
host
directli
relat
degre
durat
hypoxemia
magnitud
oxygen
diffus
defect
caus
viral
involv
lung
interstitium
sever
viral
cap
best
assess
alveolararteri
aa
gradient
patient
present
sever
viral
cap
typic
increas
aa
gradient
cxr
appear
cmv
cap
distinct
fig
cxr
help
exclud
pathogen
disord
differenti
diagnosi
either
focal
infiltr
due
typicalatyp
bacteri
cap
pathogen
disord
may
mimic
sever
cap
typic
sever
cmv
cap
present
infiltr
rapidli
follow
bilater
patchi
interstiti
infiltr
promin
lung
base
immunocompet
patient
present
otherwis
unexplain
sever
cap
minim
infiltr
bilater
symmetr
interstiti
infiltr
hypoxemia
increas
aa
gradient
cmv
includ
differenti
diagnosi
clinic
featur
cmv
suggest
cmv
versu
caus
sever
viral
cap
associ
featur
obtain
histori
physic
examin
nonspecif
laboratori
test
limit
differenti
diagnost
possibl
prompt
specif
cmv
diagnost
test
tabl
cmv
immunomodulatori
viru
may
caus
perturb
immun
disord
sle
uncommonli
patient
sle
cmv
present
flare
cap
sle
pneumon
per
se
usual
present
cap
sever
hypoxemia
clinic
problem
recogn
pulmonari
infiltr
patient
sle
flare
may
repres
cap
sle
pneumon
pneumon
character
migratori
pulmonari
infiltr
without
pleural
effus
sle
multisystem
disord
affect
nearli
organ
except
liver
patient
sle
flare
increas
serum
transaminas
cmv
suspect
caus
sle
flare
cmv
characterist
involv
liver
manifest
mild
elev
serum
transaminas
sle
patient
flare
increas
serum
transaminas
lupoid
hepat
autoimmun
hepat
view
cmvprecipit
sle
flare
prove
otherwis
cmv
induc
sle
flare
also
may
infect
lung
interstitium
present
sever
viral
cap
patient
sle
sle
pneumon
per
se
accompani
sever
hypoxemia
high
aa
gradient
sle
flare
presenc
sever
hypoxemia
increas
aa
gradient
mildli
increas
serum
transaminas
aspart
aminotransferasealanin
aminotransferas
suggest
superimpos
cmv
untreat
sle
patient
impair
humor
immun
impair
b
lymphocyt
function
patient
sle
immunosuppress
therapi
addit
impair
cellmedi
immun
cmi
tlymphocyt
function
patient
sle
cmv
intensifi
degre
immunosuppress
ie
impair
cmi
clinic
normal
host
differenti
diagnosi
sever
viral
cap
may
due
wide
varieti
virus
usual
possibl
base
epidemiolog
clinic
featur
elimin
viral
caus
present
sever
cap
avian
influenza
sar
hp
viral
caus
sever
cap
includ
human
influenza
swine
influenza
adenoviru
cmv
common
differenti
diagnost
problem
sever
viral
cap
clinic
differenti
influenza
adenoviru
cmv
sever
human
influenza
infect
characterist
clinic
present
adult
unlik
cmv
adenoviru
human
influenza
season
distribut
swine
influenza
also
consid
caus
sever
viral
cap
adenoviru
great
masquerad
may
mimic
viral
bacteri
infect
usual
rel
straightforward
differenti
influenza
adenovir
cap
cxr
appear
degre
hypoxemia
permit
clinic
differenti
influenza
adenovir
cap
rather
associ
clinic
featur
may
suggest
correct
diagnosi
clinic
featur
suggest
adenovir
cap
includ
lobar
infiltr
conjunctiv
suffus
leukopenia
rel
lymphopenia
thrombocytopenia
cmv
cap
common
season
human
influenza
swine
influenza
otherwis
unexplain
rel
lymphopenia
thrombocytopenia
howev
increas
serum
transaminas
nearli
alway
featur
cmv
may
also
occur
influenza
swine
influenza
adenovir
infect
presenc
atyp
lymphocyt
argu
diagnosi
influenza
human
avian
swine
lesser
extent
adenovir
infect
patient
viral
cap
suggest
cmv
cap
tabl
patient
present
sever
viral
cap
neg
recent
travel
zoonot
contact
histori
otherwis
unexplain
leukopenia
rel
lymphopenia
thrombocytopenia
atyp
lymphocyt
mildli
increas
serum
transaminas
suggest
cmv
cap
prompt
specif
diagnost
test
confirm
rule
cmv
although
cmv
uncommon
import
caus
sever
viral
cap
caus
late
ventilatorassoci
pneumonia
vap
lateonset
vap
unlik
cmv
present
otherwis
unexplain
hypoxemia
week
ventil
patient
lateonset
vap
often
present
failur
wean
reactiv
occur
secondari
reactiv
trauma
intub
ventil
wherea
cmv
reactiv
blood
lymphocyt
detect
cmv
antigen
posit
cmv
polymeras
chain
reaction
pcr
common
septicventil
patient
without
clinic
cmv
infect
lateonset
vap
caus
cmv
occur
rare
laboratori
test
cmv
may
diagnos
isol
viru
bodi
fluid
respiratori
secret
urin
multipl
specimen
may
need
demonstr
cmv
viruria
cmv
cultur
bodi
fluid
biopsi
specimen
suggest
infect
primari
cmv
infect
patient
becom
longterm
shedder
viru
urin
care
must
taken
interpret
clinic
signific
cmv
viruria
howev
patient
infect
compat
cmv
pathogen
isol
cmv
cultur
urin
may
diagnost
signific
immunocompet
older
children
sometim
adult
cmv
viruria
may
occur
cmv
infect
cmv
viruria
indic
infect
immunocompet
individu
uncommon
nonimmunosuppress
host
contrast
viremia
associ
immunocompet
immunosuppress
adult
cmv
viremia
may
demonstr
buffi
coat
specimen
cmv
cultur
viral
isol
human
fibroblast
cultur
observ
twice
week
cmv
cytopath
effect
cpe
cmv
cpe
resembl
hsv
first
day
cmv
cpe
chang
occur
slowli
cmv
cultur
maintain
week
report
neg
cmv
monoclon
antibodi
use
detect
cmv
cell
cultur
approxim
day
cpe
chang
becom
appar
serolog
test
serolog
test
common
method
use
demonstr
current
past
cmv
infect
diagnosi
recent
cmv
infect
depend
demonstr
either
singl
elev
cmv
igm
titer
increas
cmv
igg
titer
care
must
taken
interpret
singl
elev
cmv
igm
titer
may
fals
elev
igm
titer
patient
elev
rheumatoid
factor
rf
ebv
infect
falseposit
cmv
igm
test
result
may
occur
patient
ebv
infecti
mononucleosi
individu
may
produc
heterotyp
igm
antibodi
rf
igm
antibodi
react
igg
igm
rf
form
complex
cmv
igg
cmv
igg
bind
cmv
antigen
togeth
nonvir
rf
igm
result
falseposit
result
falseneg
result
may
occur
competit
inhibit
bind
rf
igm
cmv
antigen
reason
separ
igm
igg
titer
order
minim
incid
falseposit
falseneg
cmv
igm
result
discrep
cmv
igm
titer
clinic
present
ie
falsepositiveneg
test
rf
ebv
vca
igm
igm
titer
obtain
cmv
antigen
assay
cmv
semiquantit
antigenemia
assay
sensitivespecif
rapid
method
detect
cmv
activ
lymphocyt
import
isol
elev
level
serial
increas
cmv
antigen
titer
gener
lowtit
posit
antigenemia
indic
asymptomat
infect
usual
cmv
reactiv
infect
cmv
antigen
titer
higher
increas
time
howev
immunosuppress
patient
transplant
patient
even
low
modest
cmv
antigenemia
may
indic
reactivationinfect
cmv
pcr
cmv
pcr
sensit
indic
reactiv
cmv
lymphocyt
main
difficulti
use
cmv
pcr
distinguish
asymptomat
latent
infect
activ
infect
pcr
sensit
serial
qualit
pcr
semiquantit
cmv
antigen
level
may
clinic
use
cmv
antigenemia
high
level
increas
level
suggest
activeimpend
cmv
infect
particularli
immunocompromis
host
eg
transplant
neg
cmv
pcr
argu
strongli
reactiv
cmv
infect
importantli
immunocompet
host
primari
cmv
cap
cmv
pcr
usual
neg
cmv
produc
characterist
larg
cell
cytomegal
cell
intranuclear
basophil
inclus
cytoplasm
eosinophil
inclus
activ
cmv
infect
diagnos
demonstr
characterist
cmv
intracellular
inclus
hematoxylineosin
giemsa
wright
papanicola
stain
tissu
specimen
cmv
intranuclear
inclus
surround
clear
halo
give
typic
appear
owl
eye
dens
granular
cytoplasm
inclus
although
present
cell
diagnost
cmv
activ
infect
tabl
therapi
cmv
like
herp
virus
character
latenc
abil
evad
host
defensessurv
indefinit
abil
reactiv
result
subclin
clinic
infect
cmv
reactiv
function
host
cmi
cmv
major
problem
compromis
host
impair
cmi
steroid
immunosuppress
therapi
facilit
reactiv
cmv
immunocompet
host
cmv
infect
mildtomoder
sever
howev
case
cmv
infect
normal
host
may
sever
exclud
hiv
pcp
cmv
cap
compromis
host
particularli
organ
transplant
usual
sever
may
fatal
anticmv
therapi
may
lifesav
case
cmv
uncommon
caus
sever
viral
cap
immunocompet
adult
sever
cmv
cap
treat
cmv
antivir
often
normal
host
cmv
cap
resolv
cmv
therapi
induct
although
acyclovir
activ
herp
virus
ineffect
cmv
mainstay
anticmv
therapi
ganciclovir
mgkg
intraven
everi
hour
durat
infect
oral
equival
parenter
ganciclovir
valganciclovir
valganciclovir
metabol
ganciclovir
vivo
effect
parenter
ganciclovir
oral
valganciclovir
may
use
complet
therapi
initi
ganciclovir
therapi
may
use
entir
durat
therapi
dosag
oral
valganciclovir
induct
therapi
mg
mouth
everi
hour
day
immunocompet
host
complet
cours
therapi
ganciclovirvalganciclovir
usual
necessari
patient
usual
improv
week
therapi
patient
anticmv
therapi
often
continu
addit
week
prevent
potenti
relaps
foscarnet
altern
cmv
therapi
administ
intraven
nephrotox
decis
treat
cmv
cap
base
sever
degre
hypoxemia
treatment
cmv
cap
organ
transplant
obligatori
patient
hiv
patient
hiv
cap
may
caus
usual
typic
cap
pathogen
mycobacterium
tuberculosi
cap
patient
hiv
may
also
caus
atyp
cap
pathogen
exampl
legionnair
diseas
howev
common
cap
patient
hiv
mildmoder
decreas
cell
count
pcp
even
though
patient
hiv
definit
immunosuppress
variou
degre
impair
cmi
cmv
innoc
bystand
pathogen
patient
patient
hiv
pcp
cap
cmv
present
lung
tissu
patient
innoc
bystand
respons
hypoxemia
due
pcp
pcp
treat
patient
hiv
hypoxemia
gradual
resolv
cmv
reactiv
remain
innoc
bystand
reason
hiv
patient
pcp
cap
cmv
treat
patient
organ
transplant
cmv
cap
may
fatal
sever
cmv
cap
patient
relat
degre
impair
cmi
immunocompet
host
even
sever
cmv
cap
prognosi
good
mild
moder
sever
case
resolv
diagnosi
cmv
cap
confirm
organ
transplant
sever
cmv
cap
cmv
therapi
ganciclovirvalacyclovir
essenti
cmv
cap
immunocompet
host
even
sever
rare
requir
full
cours
anticmv
therapi
